FILTER

FILTERED INTERVIEW RESULTS

Rocco Pavese

CEO, GENETIC SPA
Genetic is an Italian CDMO founded in 2007 dedicated to the research and development, manufacturing, licensing-out and marketing of medicines.

Alessia Valducci

CEO, VALPHARMA
Valpharma is an Italian CMO involved in pharmaceutical development and contract manufacturing specializing in solid oral dosage medicines and nutraceuticals, both developed with modified-release technologies.

Giorgio Palu

PRESIDENT, AIFA
The Italian Medical Agency (AIFA) explains the current issues facing Italy’s life science industry.

Pierfrancesco Morosini

CEO, ICROM
Icrom is an Italian CDMO leader for the production of APIs and GMP intermediates.

Roel Schaapveld

CEO, INTERNA TECHNOLOGIES
InteRNA Technologies explains the promise of microRNA therapeutics.

Federico Chinni

MANAGING DIRECTOR, UCB ITALY
UCB Italy explains the specifications of the Italian health and pharma sector.

Paula Brown Stafford

PRESIDENT & CEO, NOVAN
Novan explains its vision to be the world’s leading nitric oxide-based science, technology and clinical translation company.

Dr. Donald Gerson

COO & CO-FOUNDER, SAUDIVAX
SaudiVax provides an insight into the nascent biotech industry in Saudi Arabia.

Swapnil Shah

MANAGING DIRECTOR, ESPEE GROUP
Espee Group speaks about how the demand for drugs is changing.

Fabrizio Chines

CHAIRMAN & CEO, SIFI GROUP
SIFI Group explains its pipeline and its plans for expansion in the ophthalmology space.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

Italy Lifesciences 2021

PARTNER EVENTS